Chronic renal failure. Chronic renal failure
Conditions
Interventions
Intervention 1: Intervention group: 40 micrograms HBV vaccine at the months of 0, 1, 2, 6 in patients with ESRD under dialysis. Intervention 2: Control group: 40 micrograms HBV vaccine at the months o
Prevention
Intervention group: 40 micrograms HBV vaccine at the months of 0, 1, 2, 6 in patients with ESRD under dialysis
Control group: 40 micrograms HBV vaccine at the months of 0, 1, and 6 in patients with chronic kidney disease at the stages of II - IV
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age more than18 years old, presence of Chronic Kidney Disease in the stages of 2 to 4 Exclusion criteria: Presence of severe CKD which is predicted to result in end stage renal disease over a year, HBV positive, presence of lymphoprolifrative disease, receiving immunosuppressive drugs, previous HBV vaccination
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum HBSAb. Timepoint: 3 months after the last dose of vaccination. Method of measurement: Laboratory kits. | — |
Secondary
| Measure | Time frame |
|---|---|
| HBS Ag. Timepoint: 3 months after the last dose ofl anti HBV vaccination. Method of measurement: Laboratory kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Mirzamohammadi
Zanjan University of Medical Sciences
Outcome results
None listed